Helgi Engilbertsson1, Kristina E Aaltonen2, Steinarr Björnsson3, Thorarinn Kristmundsson3, Oliver Patschan1, Lisa Rydén4, Sigurdur Gudjonsson5. 1. Department of Urology, Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden. 2. Department of Oncology, Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden. 3. Department of Vascular Surgery, Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden. 4. Department of Surgery, Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden. 5. Department of Urology, Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden. Electronic address: sigurdur.gudjonsson@skane.se.
Abstract
PURPOSE: Transurethral bladder tumor resection is the initial diagnostic procedure for bladder cancer. Hypothetically tumor resection could induce seeding of cancer cells into the circulation and subsequent metastatic disease. In this study we ascertain whether transurethral bladder tumor resection induces measurable seeding of cancer cells into the vascular system. MATERIALS AND METHODS: Patients newly diagnosed with suspected invasive bladder cancer and planned for transurethral resection of bladder tumor in 2012 to 2013 were enrolled in the study. Before transurethral bladder tumor resection a vascular surgeon placed a venous catheter in the inferior vena cava via the femoral vein. Blood samples were drawn before and during the resection from the inferior vena cava and a peripheral vein, and analyzed for circulating cancer cells using the CellSearch® system. The number of circulating tumor cells identified was compared in preoperative and intraoperative blood samples. RESULTS: The circulating tumor cell data on 16 eligible patients were analyzed. In 6 of 7 positive inferior vena cava samples (86%) the number of circulating tumor cells was increased intraoperatively (28 vs 9, 28 vs 0, 28 vs 5, 3 vs 0, 4 vs 0, 1 vs 0), and results were similar, although less conclusive, for the corresponding peripheral vein samples. CONCLUSIONS: Our study confirms that tumor cells can be released into the circulation during transurethral bladder tumor resection. It is currently unknown whether this will increase the risk of metastatic disease.
PURPOSE:Transurethral bladder tumor resection is the initial diagnostic procedure for bladder cancer. Hypothetically tumor resection could induce seeding of cancer cells into the circulation and subsequent metastatic disease. In this study we ascertain whether transurethral bladder tumor resection induces measurable seeding of cancer cells into the vascular system. MATERIALS AND METHODS:Patients newly diagnosed with suspected invasive bladder cancer and planned for transurethral resection of bladder tumor in 2012 to 2013 were enrolled in the study. Before transurethral bladder tumor resection a vascular surgeon placed a venous catheter in the inferior vena cava via the femoral vein. Blood samples were drawn before and during the resection from the inferior vena cava and a peripheral vein, and analyzed for circulating cancer cells using the CellSearch® system. The number of circulating tumor cells identified was compared in preoperative and intraoperative blood samples. RESULTS: The circulating tumor cell data on 16 eligible patients were analyzed. In 6 of 7 positive inferior vena cava samples (86%) the number of circulating tumor cells was increased intraoperatively (28 vs 9, 28 vs 0, 28 vs 5, 3 vs 0, 4 vs 0, 1 vs 0), and results were similar, although less conclusive, for the corresponding peripheral vein samples. CONCLUSIONS: Our study confirms that tumor cells can be released into the circulation during transurethral bladder tumor resection. It is currently unknown whether this will increase the risk of metastatic disease.
Authors: Jussuf T Kaifi; Miriam Kunkel; Avisnata Das; Ramdane A Harouaka; David T Dicker; Guangfu Li; Junjia Zhu; Gary A Clawson; Zhaohai Yang; Michael F Reed; Niraj J Gusani; Eric T Kimchi; Kevin F Staveley-O'Carroll; Si-Yang Zheng; Wafik S El-Deiry Journal: Cancer Biol Ther Date: 2015 Impact factor: 4.742
Authors: Jussuf T Kaifi; Guangfu Li; Gary Clawson; Eric T Kimchi; Kevin F Staveley-O'Carroll Journal: Cancer Biol Ther Date: 2016-04-05 Impact factor: 4.742
Authors: Lei Wei; Ahmed A Hussein; Yingyu Ma; Gissou Azabdaftari; Youssef Ahmed; Lai Ping Wong; Qiang Hu; Wei Luo; Victoria N Cranwell; Brittany L Bunch; Justen D Kozlowski; Prashant K Singh; Sean T Glenn; Gary Smith; Candace S Johnson; Song Liu; Khurshid A Guru Journal: J Urol Date: 2019-06 Impact factor: 7.600
Authors: Valeria Panebianco; Yoshifumi Narumi; Ersan Altun; Bernard H Bochner; Jason A Efstathiou; Shaista Hafeez; Robert Huddart; Steve Kennish; Seth Lerner; Rodolfo Montironi; Valdair F Muglia; Georg Salomon; Stephen Thomas; Hebert Alberto Vargas; J Alfred Witjes; Mitsuru Takeuchi; Jelle Barentsz; James W F Catto Journal: Eur Urol Date: 2018-05-10 Impact factor: 20.096